As home to more than 8.5 million people, Israel is an attractive location for conducting clinical studies. The population originates from many countries and ethnicities; this diversity is an advantage in generating scientifically sound clinical trial data. The scientific and medical research expertise and quality of the country’s healthcare delivery infrastructure, which is supervised by the ministry of health, make Israel an ideal environment to conduct trials.
IMP partnered with one of the oldest specialized depots in the country in 2017.
One major healthcare fund that covers 60% of the population.
Diverse, well-defined series of genetic subpopulations present a broad participant pool.
Cost advantages compared to Europe, US, and certain Asian countries.
Fast turnaround for ministry of health approval.
ICH-GCP compliant clinical trial ecosystem.
Short recruitment timelines compared to US/EU.
Services include regulatory submissions; import approval application; import coordination of investigational product and clinical trial materials; customs clearance; local storage, distribution, comparator sourcing; equipment purchase/lease; re-export and/or destruction of returned IMP.
Download the IMP Logistics Capabilities in Israel Factsheet